Piperacillin is a broad-spectrum antibiotic used to treat serious bacterial infections, including pneumonia, abdominal infections, skin infections, and pelvic infections. It belongs to the penicillin family and is almost always given in combination with a partner drug called tazobactam, which protects it from being broken down by resistant bacteria. You’ll encounter it under the combined name piperacillin/tazobactam (sometimes called “pip-tazo” in hospitals), and it’s delivered through an IV line rather than taken by mouth.
How Piperacillin Works
Like all penicillin-type antibiotics, piperacillin kills bacteria by interfering with their ability to build and maintain a cell wall. Bacteria depend on a rigid outer structure made of a mesh-like material called peptidoglycan. Piperacillin locks onto the enzymes responsible for assembling that mesh, weakening the wall until the bacterial cell breaks apart. What sets piperacillin apart from older penicillins is its extended reach: it can target a wider variety of bacteria, including many hard-to-treat species that older drugs miss.
The catch is that many bacteria have evolved enzymes that chew up penicillin-type drugs before they can do their job. This is where tazobactam comes in. Tazobactam has almost no ability to kill bacteria on its own, but it’s very good at blocking those defensive enzymes. By pairing the two drugs in a fixed 8:1 ratio (for example, 4 grams of piperacillin with 0.5 grams of tazobactam), doctors restore piperacillin’s effectiveness against bacteria that would otherwise shrug it off.
Conditions It Treats
Piperacillin/tazobactam is FDA-approved for five categories of infection:
- Intra-abdominal infections: Complicated appendicitis (where the appendix has ruptured or formed an abscess) and peritonitis, an infection of the abdominal lining. These are often caused by gut bacteria like E. coli and Bacteroides species.
- Hospital-acquired pneumonia: Moderate to severe pneumonia picked up during a hospital stay. The bacteria involved commonly include Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. When Pseudomonas is the culprit, a second antibiotic is typically added alongside pip-tazo.
- Skin and soft tissue infections: Cellulitis, abscesses, and infected diabetic foot wounds, particularly when caused by Staphylococcus aureus strains that produce resistance enzymes.
- Female pelvic infections: Postpartum uterine infections and pelvic inflammatory disease caused by E. coli.
- Community-acquired pneumonia: Moderate-severity cases caused by certain resistant strains of Haemophilus influenzae.
In practice, doctors also use piperacillin/tazobactam for a range of serious infections beyond these formal approvals, particularly in hospitalized patients with suspected mixed infections involving both common and drug-resistant bacteria.
What Bacteria It Covers
Piperacillin has one of the broadest spectrums of any penicillin-class drug. It works against gram-negative bacteria (the group that includes E. coli, Klebsiella, and Pseudomonas), many gram-positive bacteria like certain Staphylococcus strains, and anaerobic bacteria that thrive in oxygen-poor environments such as the gut and deep wounds. Its ability to kill Pseudomonas aeruginosa, a notoriously tough hospital pathogen, at lower concentrations than older penicillins like carbenicillin is one of the main reasons it remains a go-to choice in intensive care settings.
The addition of tazobactam extends that coverage further by neutralizing resistance enzymes produced by many otherwise-resistant strains. Tazobactam is particularly effective against a broad class of enzymes called class A beta-lactamases, which are among the most common resistance tools bacteria carry.
How It’s Given
Piperacillin/tazobactam is an intravenous medication, so you’ll receive it through a drip in a hospital or infusion center. The standard adult dose is 4.5 grams (4 g piperacillin plus 0.5 g tazobactam) given every six to eight hours, adding up to about 12 grams of piperacillin per day. Each infusion typically runs over 30 minutes with standard dosing, though many hospitals now use extended infusions of three to four hours because research shows this approach keeps the drug at effective levels in the blood for longer, improving its ability to clear infections.
If your kidneys aren’t working at full capacity, the dose is reduced. The adjustments are based on how well your kidneys filter waste: patients with moderately reduced kidney function move to dosing every eight hours instead of every six, and those with severely impaired function receive infusions every twelve hours. These adjustments prevent the drug from building up to unnecessarily high levels.
Children aged 2 months and older can receive piperacillin/tazobactam for abdominal infections and hospital-acquired pneumonia, with the dose calculated by body weight.
Common Side Effects
The most frequent side effects are digestive: diarrhea, nausea, vomiting, and stomach pain. Constipation, heartburn, and mouth sores also occur. Some people experience headaches, fever, or trouble sleeping. These are generally mild and resolve once treatment ends.
More serious reactions are less common but worth knowing about. Allergic reactions can include rash, hives, itching, wheezing, or difficulty breathing. Severe diarrhea, especially if watery or bloody, can signal a secondary gut infection caused by Clostridioides difficile, a bacterium that sometimes overgrows when antibiotics wipe out normal intestinal bacteria. This complication can surface up to two months after treatment finishes.
Allergy and Cross-Reactivity
Because piperacillin is a penicillin, anyone with a confirmed penicillin allergy needs careful evaluation before receiving it. Hypersensitivity reactions to piperacillin/tazobactam are actually reported less frequently than with many other penicillins. In a large multicenter study, about one-third of patients who reacted to piperacillin/tazobactam were also allergic to other penicillins. Notably, 21 patients in that study who were selectively sensitized to piperacillin/tazobactam tolerated other penicillin-type antibiotics without problems, meaning the allergy was specific to this drug rather than the whole penicillin class. A small number of cases raised the possibility that the tazobactam component, rather than piperacillin itself, was the trigger.